Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir vs Insulin Glargine in Type 1 Diabetes
NCT00312104Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2002
- Primary completion
- Mar 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Apr 2002; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00312104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312104.